HilleVax (HLVX) Expected to Announce Quarterly Earnings on Wednesday

HilleVax (NASDAQ:HLVX) is expected to announce its earnings results before the market opens on Wednesday, March 19th. Analysts expect the company to announce earnings of ($0.38) per share for the quarter.

HilleVax Stock Up 1.1 %

HLVX opened at $1.77 on Tuesday. The firm has a market capitalization of $88.16 million, a P/E ratio of -0.57 and a beta of 0.76. The firm’s 50 day moving average is $1.88 and its 200-day moving average is $1.87. HilleVax has a 52-week low of $1.55 and a 52-week high of $18.00.

About HilleVax

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.